CALM3 and melanoma: Furthermore, two other CaM antagonists, J8 (N-8-aminooctyl-5-iodo-naphthalenesulfonamide) and tamoxifen, have the capacity to inhibit attachment of melanoma cells to the extracellular matrix and hence their invasiveness [74,78,326].